National Cancer Institute Home at the National Institutes of Health | www.cancer.gov

Awarded NIH Grants

Look up grants by number in NIH's RePORTER query tool.

Population Science Studies
Project Title Grant Number Principal Investigator Institution Sample Size Diagnosis Years Project Start & End Years
Risk Factors for Ductal Carcinoma In Situ 5R03CA103478-02 Brody, Julia Silent Spring Institute n=224 patients from the Cape Cod Breast Cancer and Environment Study 1992-1998 2003-2006
Breast Carcinoma In-Situ: Mammographic Risk Factors 5R01CA095560-03 Claus, Elizabeth Yale University n=875 with DCIS; n=123 with LCIS who are CT residents; n=999 controls 1994-1998 2004-2010
Cost-Effectiveness -- Treatments -- Ductal Carcinoma In Situ 5R01CA092444-02 Dick, Andrew / Griggs, Jennifer University of Rochester SEER-Medicare   2002-2005
Microsatellite Markers of DCIS Prognosis 5R21CA081442-02 Gabrielson, Edward Johns Hopkins Universtiy     1999-2002
Risk Stratification for Subsequent Tumors in Women with DCIS 5P50CA058207-15001209 Gray, Joe University of California, San Francisco Large, established, well-characterized population-based cohort of women with DCIS treated by lumpectomy alone with 8.1 years of follow-up    
Etiology of Early Breast Malignancy 5R01CA072025-04 Greenberg, Robert Dartmouth College n=412 women with DCIS from NH and VT cancer registries
n=412 women with invasive breast cancer
  1996-2002
DCIS--Mammographic features and prognosis  5R01CA081302-05 Habel, Laurel Kaiser Foundation Research Institute n=1200 women with DCIS from the Northern California Kaiser Permanente Medical Care Program  1990-1997 1999-2005
Mammographic density and breast cancer after diagnosis of DCIS 5R03CA083135-02 Habel, Laurel Kaiser Foundation Research Institute n=814 patients from the National Surgical Adjuvant Breast and Bowel Program Clinical Trial   1999-2002
Clinical/Pathologic Predictors for Recurrence after DCIS 2U19CA079689-050001 Habel, Laurel Kaiser Foundation Research Institute n=3700 patients (n=490 with recurrence) from the CRN, Kaiser Permanente Northern California, Kaiser Permanente Souther California, Harvard Pilgrim Health Care 1990-2001 2003-2007
Surgical Treatment for Early State Breast Cancer 5R01CA088370-03 Katz, Steven University of Michigan, Ann Arbor n=1880 patients from SEER catchment areas   2001-2005
Predictors of Recurrence in Women with DCIS 2P50CA058207-090011 Kerlikowse, Karla University of California, San Francisco n=1,744 from Northern California SEER
n=457 from UCSF for the Breast Oncology Program database
n=1,3 10 women from the NSABPB-17 and NSABPB-24 trials.
1983-1996 2003-2007
Radiation and Genomic Instability in Finite Lifespan Human Mammary Epi 1R21ES016889-01A1 Kronenberg, Amy University of California Mammary epithelial cells   2009-2011
Treatment Decisions Comparing DCIS/Invasive BC patients 1R03CA075140-01A1 Lantz, Paula University of Michigan, Ann Arbor n=200 patients with DCIS or invasive breast cancer reported to Detroit SEER Registry   1997-1999
Breast Cancer: Role of Early Detection, Treatment and Prevention 5U01CA088270-07 Lee, Sandra J. Dana-Farber Cancer Institute SEER data 2000-2009
Risk Factors for Second Primary Breast Cancer Among DCIS Survivors 5R01CA097271-07 Li, Christopher Fred Hutchinson Cancer Research Center n=515 cases diagnosed with DCIS and a subsequent second primary in situ or invasive breast cancer, n=1,030 controls with DCIS only   2002-2014
A Video DVD Program to Assist with Informed Consent 1R43CA103264-01A1 Love, Neil NL Communications, Inc n=3000   2004-2005
Case-Control Study of Carcinoma In Situ 3P50CA058223-08S20011 Millikan, Bob University of North Carolina Chapel Hill n=400 cases of DCIS or LCIS from the Carolina Breast Cancer Study and frequency-matched controls 1995-2000 Not listed
Risk Factors and Biomarkers for In Situ Breast Cancer 5R01CA067264-04 Newcomb, Polly and Titus-Ernstoff, Linda  Fred Hutchinson Cancer Research Center and Dartmouth College n=1575 cases of DCIS or LCIS from WI, MA, and NH state cancer registries
n=2205 population-based controls
  1996-2002
Cost Effectiveness Analysis of Breast Cancer Screening 5R01CA082904-03 Plevritis, Sylvia Stanford University     1999-2003
Breast Cancer Trend Analysis Using Stochastic Stimulati 3U01CA088248-04S1 Plevritis, Sylvia Stanford University     2000-2011
Decision-making Regarding Radiation Therapy in Breast Cacner 5K07CA118269-05 Punglia, Rinaa Dana Farber Cancer Institute SEER-Medicare data   2006-2011
Environmental and Genetic Risk Factors for Breast Cancer: The Sister Study 1ZIAES044005-12 Sandler, Dale National Institute of Environmental Health Sciences NIEHS Sister Study 2004-2009 Ongoing
Breast Carcinoma in Situ: Predicting Risk and Outcomes 5R01CA067264-12 Trentham-Dietz, Amy University of Wisconsin, Madison n=2,352 cases from large, population-based cohort n=>5,000 controls   1996-2014

[Return to top]

Clinical Studies
Project Title Grant Number Principal Investigator Institution Sample Size Project Start & End Years
Clinical Study of the Disposition and Biological Activity of d-Limonene   Chow, Sherry University of Arizona Women with a recent diagnosis of DCIS, LCIS, or atypical ductal hyperplasia 2009-2011
A her-2/neu Pulsed DC1 Vaccine for Patients with DCIS 5R01CA096997-03 Czerniecki, Brian University of Pennsylvania Practice-based recruitment 2003-2012
Addressing the Challenges in Transitioning from Mammography to Breast Tomosynthesis 5K25CA140858-02 Das, Mini University of Massachusetts   2009-2014
Accuracy of Breast Pathology and the Impact of Technology and Double Reading 1R01CA140560-01 Elmore, Joann University of Washington Women undergoing breast biopsy 2009-2014
Cytogenic Screening of Mammary Epithelial Cells 5R21CA084712-02 Haddad, Bassem Georgetown University n=50 controls; n=50 women with atypical ductal hyperplasia; n=50 women with DCIS; n=50 women with stage 1 breast cancer 2000-2003
Quantitative Mechanical Imaging for Improving Breast Ultrasound Diagnosis 1R01CA140271-01 Hall, Timothy University of Wisconsin Madison   2009-2014
High-resolution Whole-breast MRI at 3.0T 5R01EB009055-02 Hargreaves, Brian Stanford University Small patient study 2008-2012
Primary Hormonal Therapy for DCIS of the Breast 5K23CA097181-04 Hwang, Shelley University of California, San Francisco n=40 postmenopausal patients with DCIS 2004-2010
MRI for Staging DCIS and Assessing Response to Treatment 1R01CA116182-01A1 Hylton, Nola University of California, San Francisco Patients with biopsy-proven DCIS 2006-2011
A Trial of Exemestane in Postmenopausal Women with DCIS or at High Risk for Invasive Breast Cancer 5M01RR023942-03 Isaacs, Claudine Georgetown University Women with DCIS or high risk of breast cancer 2009-2010
PNI and Decision Making in Women Diagnosed with DCIS 5R01NR008412-04 Janusek, Linda Loyola University of Chicago n=122 women with newly diagnosed DCIS 2004-2008
Quality of Life Over Time: DCIS vs Early Breast Cancer 5R01CA102777-04 Jeffe, Donna Washington University Women with normal or benign mammograms will be identified surgeons 2003-2010
Synergy of Inverse Scatter & Vibro-Acoustics 1R43CA105916-01 Johnson, Steven Techniscan, Inc Patients selected from a population with positive mammograms for micro calcifications 2004-2006
Fast Spectroscopic MR Imaging of Breast Cancer 5R01CA078803-07 Karczmar, Gregory University of Chicago n=300 women scheduled for routine MRI exams prior to biopsy 1999-2008
A Tool for Analysis of Gene-specific DNA Methylation in Clinical Samples 5R21RR024420-03 Levenson, Victor Rush University Medical Center   2009-2011
Determination of Distinct Types of Immune Responses to HER-2/neu Associated With… 5M01RR000065-47 Manjili, Masoud Virginia Commonwealth University Women with HER-2/neu positive or negative DCIS and invasive breast cancer 2009-2010
Immune Dysregulation by Psychosocial Distress 5R21CA117261-02 Mathews, Herbert Loyola University of Chicago Women diagnosed with DCIS 2005-2008
Interactive Decision Making Program for DCIS 5R03CA070717-02 Mort, Elizabeth Massachusetts General Hospital   1995-1999
New Approaches to Sampling and Analyzing Contrast Media 5R21CA104774-02 Newstead, Gillian University of Chicago n=150 patients per year 2005-2008
Cyclin E Expression in Human Cancer 5R01CA071735-06 Porter, Peggy Fred Hutchinson Cancer Research Center n=225 tissue samples from women with DCIS
n=913 tissue samples from women with invasive breast cancer
2000-2004
Sulforaphane: A Dietary HDAC Inhibitor and Prevention of DCIS Progression 1R21CA132236-01A2 Shannon, Jackilen Oregon Health and Science University   2009-2011
Genetic Predictors of Progression of Premalignant Breast Disease 5P50CA098131-07000809 Smith, Jeffrey Vanderbilt University Samples of breast tissue from a cohort of 7,923 women 2009-2011
Point-of-Care Microfluidics for Early Detection of Cancer 1U01EB012493-01 Toner, Mehmet Massachusetts General Hospital   2010-2015
Detecting Breast Cancer Protein Signatures in Body Fluid 5U01CA085082-05 Trock, Bruce Johns Hopkins University fresh tumor tissue that contains invasive, in-situ and abnormal components; body fluids from women with normal breasts, DCIS, and stage 1 cancer 1999-2005
EGFR Pathway Modulation in DCIS of the Breast 5R21CA101357-02 Truica, Christina Vanderbilt University Patients with DCIS 2003-2005
Ex Vivo Clinical Raman Spectroscopy of Breast Cancer 5P41RR002594-25 Volynskaya, Zoya Massachusetts Institute of Technology   2010-2011
The Cancer Research Network (CRN) - Clinical and Pathologic Predictors for Recurrence after DCIS 3U19CA079689-08S2 Wagner, Edward H. Group Health Research Institute HMO-CRN data 1999-2007
Psychosocial outcomes/health behaviors: women with DCIS 3P50CA089393-05S20007 Winer, Eric Dana Farber Cancer Institute n=450 women from academic and community health care institutions Not listed

[Return to top]

Basic Science Studies
Project Title Grant Number Principal Investigator Institution Sample Project Start & End Years
Molecular Classification and Prognostic Profiling of Ductal Carcinoma in Situ 2P50CA058183-090010 Allred, Craig Baylor College of Medicine n=25 fresh-frozen DCIS samples and matched cases of normal breast and invasive breast cancer 2003-2007
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ 1K99CA127462-01 Behbod, Fariba University of Kansas Medical Center Premalignant cell lines and subtypes of human DCIS 2007-2011
Role of Stat3 in Breast Cancer Tumorigenesis 3R01CA087637-05S1 Bromberg, Jacqueline Sloan-Kettering Institute for Cancer Research Cell lines, transgenic animals, human tissue 2001-2006
Genetic Pathways Altered by MMTV in Mouse Mammary Tumors 1ZIABC011066-03 Callahan, Robert NCI Division of Basic Sciences Mouse model 2008-2010
Telomere induced senescence as a suppressor of tumorigenesis 1R01CA129037-01 Chang, Sandy S. University of Texas MD Anderson Can Ctr Mouse model 2007-2012
Characterization of the Chromosome 17q23 Amplicon 5R01CA087898-05 Couch, Fergus Mayo Clinic College of Medicine Breast tumors and cell lines 2002-2008
VPF/VEGF in Breast Cancer Angiogenesis 5R01HL054465-04 Dvorak, Harold Beth Israel Deaconess Medical Center Human breast lesions and carcinomas from mice 1995-2000
HER4 Isoforms: Tumor Suppressor Action and Prognostic Significance 5P50CA058223-17002509 Earp, Henry University of North Carolina Chapel Hill Human breast cancer cells; Mouse model 2009-2011
Expression of Aryl Hydrocarbon Receptor in Breast Tumors 5U54CA091408-020004 Elton, Sakina Meharry Medical College Human breast cancer cell lines Not listed
Integrated Biomarkers to Characterize Breast Cancer Risk 5U01CA111234-03 Esserman, Laura University of California San Francisco   2004-2009
Development and Validation of a Panel of Breast Cancer for the Early Diagnosis of 1R01CA122277-01A2 Fernandez-Madrid, Felix Wayne State University Human sera 2008-2011
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas 5R01CA107012-07 Friedl, Andreas University of Wisconsin Human breast carcinoma samples 2004-2015
A Hypersensitive ERa Mutant in Breast Cancer Progression 5R01CA072038-10 Fuqua, Suzanne Baylor College of Medicine Clinical breast tumor bank 1996-2008
Molecular Variants of Estrogen and Progesterone Receptors in Breast Cancer 5P01CA030195-160014 Fuqua, Suzanne Baylor College of Medicine   Not listed
Mechanisms Regulating Reversal of Malignancy 5R01CA089041-08 Furth, Priscilla Georgetown University Mouse model 2006-2010
Progression and Regression of Mammary Preneoplasia 5R01CA112176-03 Furth, Priscilla Georgetown University Mouse model 2004-2009
Somatic Genetic Changes in Early Breast Cancer 5R21CA106676-03 Geradts, Joseph Roswell Park Cancer Institute n=35 low grade DCIS samples, n=35 low grade DCIS samples associated with an invasive component 2005-2008
Immunologic Studies in Mouse and Human Breast Cancer   Girardi, Anthony Coriell Institute for Medical Research    
Secreted Proteins as Breast Cancer Prevention Markers 5R01CA101201-05 Gould, Michael University of Wisconsin, Madison Rat model 2003-2008
Neu Activation and the Etiology of Mammary Cancer 5R01CA058328-05 Gould, Michael University of Wisconsin, Madison Cell lines  1993-1999
Characterizing a Breast Cancer Modifier Locus that Associated with Human Risk 1R01CA123272-01 Gould, Michael University of Wisconsin, Madison Rat models and human studies 2006-2011
Modulation of Carcinogenesis by Monoterpenoids 2R37CA038128-10 Gould, Michael University of Wisconsin, Madison Cell lines 1984-2000
Chemoprevention in a Mouse Model of DCIS 1R03CA117465-01A2 Gregg, Jeffrey University of California, Davis Mouse model 2007-2009
R-Cadherin in Breast Cancer Suppression 5R01CA136854-02 Hazan, Rachel Albert Einstein College of Medicine Cell lines 2009-2014
Autoantibodies Against Glycopeptide Epitopes as Serum Biomarkers of Cancer 1U01CA128437-01 Hollingsworth, Michael A University of Nebraska Medical Center Human tissue samples 2007-2012
Beta-Catenin/TCF Signaling in Breast Cancer 1R01CA131219-01A1 Howe, Louise R. Weill Medical College of Cornell Univ. Precancerous breast lesions and invasive breast cancers 2008-2013
CPG Island Methylator Phenotypes in Breast Cancer 2R01CA069065-10A1 Huang, Tim H-M Ohio State Universtiy Human breast tumors 2007-2012
Wwox as a Critical Signal Mediator in Breast Can 5R01CA120516-02 Huebner, Kay Ohio State Universtiy Breast cancer cell line and tissue 2006-2009
Discovery and Clinical Validation of Cancer Biomarkers Using Printed Glycan Array 1U01CA128526-01 Huflejt, Margaret Elisabeth Cellexicon, Inc. Human sera 2007-2012
Cancer Prevention by Selenium-Enriched Allium Vegetables 5R01CA027706-23 Ip, Clement  Roswell Park Cancer Institute   1980-2005
Molecular biomarkers of selenium chemoprevention 5R01CA091990-05 Ip, Clement  Roswell Park Cancer Institute Human breast cell lines, mouse and rat models 2002-2008
Pilot -- AH Receptor in Human Breast Tumors 5U54CA091405-020004 Jensen, Roy Vanderbilt University Human breast carcinoma cell lines Not listed
Characterizing the Evolution of Pre-malignant Tissues at High Risk for Malignancy 5R01CA135626-02 Jones, Ella University of California San Francisco    
Biophysical Regulation of Breast Differentiation 5R01CA114462-02 Keely, Patricia J University of Wisconsin Human breast carcinoma samples 2010-2014
Role of EZH2 in Breast Cancer Progression 2R01CA107469-06A1 Kleer, Celina G. University of Michigan at Ann Arbor Human tissue samples and mouse models 2004-2015
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer 1R01CA125577-01A1 Kleer, Celina G. University of Michigan at Ann Arbor Human tissue samples and mouse models 2008-2013
Characterization of HIN1 Putative Tumor Supressor 5F32CA094787-02 Krop, Ian Dana Farber Cancer Institute Normal and DCIS mammary epithelial cells 2002-2003
DNA Repair and Breast Cancer 5R29CA071894-05 Latimer, Jean Magee Women's Health Corporation Tumor and non-tumor breast epithelium 1997-2005
Genomic Instability and Etiology of Extrogen Oncogenesis 5R01CA102849-05 Li, Jonathan University of Kansas Medical Center   2003-2008
Application of Genomic Microarrays to Breast Cancer 5K01CA093634-05 Lucito, Robert Cold Spring Harbor Laboratory   2002-2007
Differential Protein Expression by MALDI TOF MS 5R21CA083808-02 Lubman, David University of Michigan, Ann Arbor Human breast epithelial cell line 2001-2004
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease R01CA131990-02 Mattingly, Raymond Wayne State University Cell lines 2008-2013
Functional Genomics of Breast Cancer 1ZIABC011088-03 Meltzer, Paul S NCI Division of Basic Sciences   2009-2010
MCF10DCIS.com As a Preclinical Chemopreventive Screen 5R03CA094333-02 Miller, Fred Wayne State University Human breast epithelial cell line 2002-2005
Proteomics of Progression in MCF10 Xenograft Model 5R01CA090503-04 Miller, Fred Wayne State University Human breast cell line  2002-2007
VP Peptides and Receptors in Diagnosis of Breast Cancer 5R21CA102434-02 North, William Dartmouth College   2005-2007
GRSA Proteins in the Diagnosis of Breast Cancer 5R21CA092506-02 North, William Dartmouth College   2001-2004
Molecular Genetic Markers of Pre-Malignant and Pre-Invasive Breast Disease 3P50CA058183-08S80004 O'Connell, Peter University of Texas Health Sciences Center Breast cancer specimens Not listed
Translational Research in Breast Cancer 5P50CA058183-13 Osborne, Kent Baylor College of Medicine   1992-2007
Treatment of Breast Cancer with MAG-1 Antibody 5R44CA119483-03 Pang, Roy Woomera Therapeutics, Inc. Mouse model 2006-2011
Manipulating b1 integrin to enhance radiation therapy for breast cancer 1R01CA124891-01A2 Park, Catherine C. University of Calif-Lawrenc Berkeley Lab Cell lines 2008-2013
Human Aldo Keto Reductases and Steroid Hormone Ac 5R01CA090744-05 Penning, Trevor University of Pennsylvania Human breast cell lines and biopsy samples 2001-2007
Molecular Characterization of Breast Basal-like Tumors 5R01CA101227-05 Perou, Charles University of North Carolina Chapel Hill Human basal-like tumors; Mouse mammary tumors 2003-2010
Breast stem cell analysis in random periareolar fine needle aspirates from high r 1R03CA121417-01A1 Petroff, Brian University of Kansas Medical Center Samples of breast tissue from women at high risk for breast cancer 2007-2009
Myoepithelial Cell Differentiation Defects in Ductal Carcinoma in situ 5U01CA143233-02 Polyak, Kornelia Dana Farber Cancer Institute Human breast tissue 2009-2014
Molecular Markers in DCIS 3P50CA089393-05S20004 Polyak, Kornelia Dana Farber Cancer Institute Benign, in situ, invasive breast tissue Not listed
HIN-1, A Novel Putative Breast Tumor Supressor Gene 5R01CA094074-05 Polyak, Kornelia and Porter, Dale Dana Farber Cancer Institute Normal and cancerous breast tissue, and mouse model 2002-2008
Identification of Receptor for Tumor Suppressor HIN-1 5F32CA094788-02 Porter, Dale Dana Farber Cancer Institute Mammary epithelial cells 2002-2004
Epithelial-Stromal Cell Interactions in Breast Cancer 1R01CA116235-01A1 Polyak, Kornelia Dana Farber Cancer Institute Human xenograft models in mice and human breast tumors 2006-2011
Immune Response to Breast Ductal Carcinoma In Situ 5K11AI001092-05 Pruitt, Scott Duke University Guinea pig-to-Lewis rat model 1992-2000
Genetic Signatures of Preinvasive Breast Disease 1R21CA115434-01A2 Rosenberg, Carol Boston Medical Center Breast cancer-containing tissue 2007-2009
Molecular Basis of Breast Cell Transformation 3R01CA067238-04S3 Russo, Jose Fox Chase Cancer Center Human breast epithelial cells 1995-2000
Centrosome Hypertrophy in Human Breast Tumors 5R01CA072836-04 Salisbury, Jeffrey Mayo Clinic College of Medicine Normal breast epithelial and breast tumor cell lines, and human breast tissue 1998-2001
The Role of Cripto in the Pathogeneis of Breast and Colon Cancer 1Z01BC009003-24 Salomon, David National Cancer Institute   Ongoing
Prevention of Breast Cancer with Sphingolipids 5R03CA101125-02 Schmelz, Eva Wayne State University Cell models for early and late stages of breast cancer 2003-2006
IRS-2 Function in Tumor Progression and Metastasis 1R01CA142782-01A1 Shaw, Leslie University of Massachusetts Breast cancer cells 2010-2015
Proteolytic Pathways in Progression of Pre-malignant Breast Disease 5R01CA131990-03 Sloane, Bonnie Wayne State University Cell lines 2008-2013
Molecular Markers for High Risk of Breast Cancer 3P50CA058207-08S50003 Smith, Helene University of California, San Francisco Cases of pure DCIS and DCIS associated with invasive cancers, and nonmalignant epithelium samples Not listed
Technology for Global and Quantitative Proteome Analysis 1R21CA093306-01 Smith, Richard Battelle Pacific Northwest Laboratories  Breast tissue 2001-2003
Mechanisms of Mammary Gland Carcinogenesis of Heterocycl 1Z01BC010037-10 Snyderwine, Elizabeth National Cancer Institute Rat model, human breast tissue 2005
Molecular Alterations in Premalignant and In-Situ Breast 1Z01SC009377-13 Steeg, Patricia
  Cell lines Not listed
Molecular Markers for Breast Cancer 1P50CA088843-010001 Sukumar, Saraswati Johns Hopkins University Large panel of breast tumors 2000-2011
Selenium and Apoptosis in Cancer Prevention 5P01CA045164-120005 Thompson, Henry AMC Cancer Researh Center Rat model Not listed
Iron and Mammary Carcinogenesis 5R01CA069241-03 Thompson, Henry AMC Cancer Researh Center Rat model 1996-2000
Characterizing the Evolution of Pre-malignant Tissues at High Risk for Malignancy 5R01CA135626-03 Tlsty, Thea University of California, San Francisco Breast tissue 2008-2011
Risk Marker/Chemoprevention Target Identification 2P50CA058207-090009 Tlsty, Thea
University of California, San Francisco Human mammary epithelial cells and human breast tissue 2003-2007
Developing mRNA Diagnostic Methods and Identifying Tumor Regulatory Networks 5RC1CA145442-02 Tuschl, Thomas Rockefeller University Human tissue samples 2009-2011
Psychosocial modulation of mammary carcinogenesis 1F31CA130267-01 Yee, Jason Richard University of Chicago Rat model 2007-2010
14-3-3zeta in ErbB2 Mediated Mammary Carcinogenesis 5R01CA112567-03 Yu, Dihua University of Texas MD Anderson Cancer Center Mammary epithelial cells 2005-2010
14-3-3zeta in Early Stages of Breast Cancer Progression 5R01CA109570-03 Yu, Dihua University of Texas MD Anderson Cancer Center Mammary epithelial cells and tissues from patients 2004-2010
Green tea catechins in precancerorus prevention 1R21CA129772-01A2 Wang, Hwa-Chain Robert University of Tennessee Knoxville Cellular model 2008-2010
Gene Amplification in Breast Cancer 2P50CA068425-040007 Wigler, Michael Sloan-Kettering Institute for Cancer Research   Not listed

[Return to top]

Other Studies
Project Title Grant Number Principal Investigator Institution Project Start & End Years
SPORE in Breast Cancer 5P50CA098131-04 Arteaga, Carlos L  Vanderbilt University 2003-2008
SPORE in Breast Cancer 3P50CA089019-05S7 Bland, Kirby University of Alabama 2000-2007
SPORE in Breast Cancer 2P50CA088843-06A1 Sukumar, Sara Johns Hopkins University 2000-2011
SPORE in Breast Cancer 2P50CA058223-09A1 Earp, H University of North Carolina, Chapel Hill 1992-2006
SPORE in Breast Cancer 5P50CA058207-13 Gray, Joe University of California San Francisco 1992-2007
SPORE in Breast Cancer 2P50CA089393-06 Iglehart, James Dana Farber Cancer Institute/Harvard 2000-2008
San Francisco Mammography Registry -- A Research Resource 5U01CA063740-12 Kerlikowske, Karla University of California, San Francisco 1994-2010
High Risk Patients and Families Core 3P50CA089393-05S29001 Li, Frederick Dana Farber Cancer Institute Not listed
Tissue and Outcomes Core 2P50CA058207-099001 Ljung, Britt-Marie University of California, San Francisco 2003-2010
Biostatistics Core 5P50CA058207-16 Moore, Dan University of California, San Francisco 2009-2010
Translational Research in Breast Cancer 2P50CA058183-09 Osborne, C Kent Baylor College of Medicine 1992-2007
Cell Resources Core 5P30CA022453-269016 Pauley, Robert Wayne State University Not listed
Pathology Core 3P50CA068425-05S19001 Rosen, Peter Sloan-Kettering Institute for Cancer Research Not listed
Human Specimen Resource and Database Core 5P50CA088843-039002 Sherman, Mark Johns Hopkins University Not listed
Breast Cancer Cell Line Resource Core 3P50CA058185-08S49001 Ziff, Barbara Georgetown University Not listed

[Return to top]

Last Modified: 18 Oct 2013